Production (Stage)
Bruker Corporation
BRKR
$35.50
-$0.84-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.84% | 13.56% | 15.26% | 15.19% | 14.77% |
| Total Other Revenue | -- | -- | 47.19% | 27.18% | 9.17% |
| Total Revenue | 14.84% | 13.56% | 15.00% | 14.93% | 14.49% |
| Cost of Revenue | 16.48% | 16.48% | 18.61% | 17.61% | 17.57% |
| Gross Profit | 13.23% | 10.78% | 11.60% | 12.42% | 11.64% |
| SG&A Expenses | 21.40% | 22.76% | 24.91% | 22.27% | 19.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -44.32% | -53.09% | 141.25% | 3,566.67% | 260.00% |
| Total Operating Expenses | 19.04% | 19.43% | 22.15% | 20.51% | 19.55% |
| Operating Income | -9.52% | -16.17% | -19.55% | -10.74% | -8.03% |
| Income Before Tax | -68.89% | -62.43% | -7.95% | 4.68% | 19.27% |
| Income Tax Expenses | -25.37% | -22.34% | -15.58% | -9.27% | -5.94% |
| Earnings from Continuing Operations | -80.50% | -73.44% | -5.49% | 9.63% | 28.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 166.67% | 46.15% | 112.90% | 71.43% | 34.78% |
| Net Income | -80.18% | -73.53% | -4.45% | 10.34% | 28.92% |
| EBIT | -9.52% | -16.17% | -19.55% | -10.74% | -8.03% |
| EBITDA | 5.81% | -1.69% | -4.84% | -0.83% | -1.10% |
| EPS Basic | -80.86% | -73.91% | -4.08% | 11.41% | 30.38% |
| Normalized Basic EPS | -14.75% | -15.79% | -18.19% | -8.35% | -5.41% |
| EPS Diluted | -81.06% | -73.94% | -4.27% | 11.44% | 30.70% |
| Normalized Diluted EPS | -14.61% | -15.68% | -18.06% | -8.23% | -5.33% |
| Average Basic Shares Outstanding | 3.08% | 1.71% | 0.39% | -0.65% | -1.12% |
| Average Diluted Shares Outstanding | 2.90% | 1.58% | 0.24% | -0.78% | -1.18% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 4.27% | 2.88% | 0.06% | -0.09% | -0.23% |